Thursday, 10 December 2015

Molecular Biomarkers-2016

About Conference


OMICS International welcomes you to the 'International Conference and Expo on Molecular & Cancer Biomarkers' to be held from September 15-16, 2016 in Berlin, Germany. OMICS International organizes 3000+ Global events in conference series every year across  the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.

The global cancer biomarkers market for 2007 was $3.6 billion and is expected to grow at a CAGR (Compounded Annual Growth Rate) of 6.3% to reach $6.3 billion by 2016. A number of factors such as the rising demand for personalized medicine and companion diagnostics have increased the utility of biomarkers in the healthcare sector. The global biomarkers market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018. The cancer biomarker conferences are very much encouraged to spread the knowledge of advances in these days.

Molecular Biomarkers 2016 is organized around the theme: “Latest discoveries and innovations in the field of Molecular and Cancer Biomarkers”.

Molecular biomarkers will, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis, and disease management. Molecular biomarkers have the additional potential to identify individuals susceptible to disease. There is a good scope to know more in this molecular biomarkers meeting. In the recent years, knowledge about cancer biomarkers has increased tremendously providing great opportunities for improving the management of cancer patients by enhancing the efficiency of detection and efficacy of treatment. Recent technological advancement has enabled the examination of many potential biomarkers and renewed interest in developing new biomarkers. All such developments can be evidenced in this molecular biomarker conference.

A comprehensive discussion of the significance of each biomarker like pharmacodynamics and toxicodynamics of protein biomarkers, analytical biomarkers, and epigenetic biomarkers is going to be held in this biomarkers congress. This conference also includes symposiums and workshop events.

Why to attend???

With members from around the world focused on learning about molecular and cancer biomarkers, and its advances; this is your best opportunity to reach the largest assemblage of participants from the biomarker community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in molecular and cancer biomarkers are hallmarks of this conference.

 Target Audience:

  • Biomarker research Students, Scientists
  • Biomarker Researchers
  • Cancer Researchers
  • Biomarker Faculty
  • Medical Colleges
  • Biomarker Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Pharmaceutical Companies
  • Diagnostics Companies

Conference Highlights

  • Molecular Biomarkers
  • Cancer Biomarkers
  • Clinical Biomarkers
  • Biomarkers and Cancers
  • Biomarkers and Non-cancerous diseases
  • Cell Free Biomarkers
  • Predictive Cancer Biomarkers
  • Molecular Biomarkers Discovery
  • Biomarkers: Validation and Verification
  • Advances of Biomarker testing
  • Biomarkers and Personalized Medicine
  • Companion Diagnostics
  • Biomarkers and Pharmacology
  • Molecular Imaging and Dynamics
  • Biomarkers and Oncologists
  • Case Reports
  • Biomarkers Entrepreneurs Investment Meet

Special Issues

  •  All accepted abstracts will be published in respective OMICS International Journals.
  •  Abstracts will be provided with Digital Object Identifier by Cross Ref.

No comments:

Post a Comment